Share Name Share Symbol Market Type Share ISIN Share Description
Itaconix Plc LSE:ITX London Ordinary Share GB00B84LVH87 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.35 -5.07% 6.55 1,361,320 16:16:43
Bid Price Offer Price High Price Low Price Open Price
6.50 6.60 6.90 6.55 6.90
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 3.29 -1.65 -0.50 28
Last Trade Time Trade Type Trade Size Trade Price Currency
16:20:59 O 5,000 6.60 GBX

Itaconix (ITX) Latest News

More Itaconix News
Itaconix Investors    Itaconix Takeover Rumours

Itaconix (ITX) Discussions and Chat

Itaconix Forums and Chat

Date Time Title Posts
30/7/202122:39GET OUT BEFORE ITS TOO LATE!!!!(11/04/02)60
30/7/202120:14Itaconix formerly Revolymer7,382
16/6/202115:37where's lucky34
16/6/202114:54Inter_X holders ready to do a big brown plop soon152
16/6/202114:45Anyone still holding any of this ?28

Add a New Thread

Itaconix (ITX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Itaconix trades in real-time

Itaconix (ITX) Top Chat Posts

Itaconix Daily Update: Itaconix Plc is listed in the Chemicals sector of the London Stock Exchange with ticker ITX. The last closing price for Itaconix was 6.90p.
Itaconix Plc has a 4 week average price of 6.55p and a 12 week average price of 6.55p.
The 1 year high share price is 17.45p while the 1 year low share price is currently 1.25p.
There are currently 432,448,253 shares in issue and the average daily traded volume is 4,989,819 shares. The market capitalisation of Itaconix Plc is £28,325,360.57.
purchaseatthetop: lefrene...clearly there were major issues in H1 2021 relating to covid19 that materially reduced earnings. Despite this H1 income rose 26% compared to the same period 2020. It seems that the impact of covid was delayed on ITX and actually it helped in H2 2020. That has now come home to bite. The extra H2 2020 income caused the share price spike as we did not know it was skewed income. The new II at 12.1p clearly knows that H2 2021 will be a lot better than the news we got. Otherwise WTF would they invest? I think we have all the bad news out of the way now and hopefully things will calm down and slowly rise. As always this is a guess. The ITX IP has not changed. It is still key to customers in growing numbers. Nothing is ever easy and we have found that out recently.
lefrene: dandu69, the thing is with small speccy companies you never have the full story, and there's always the founders doing their best to enrich themselves (which is fair enough) but with the share holders taking second place. Thanks to the expertise of some posters here, we do know that the range of products grows rapidly, and those products are on the shelves in the market place. All that's happened here is that for reasons unknown the management has chosen to be flat blunt in their rns, presumably knowing what that bluntness would do to the share price. It seems to me that demand for ITX patented product is growing apace but due to the current covid hiatus there is some disruption in supply and consequently delayed cash flows. The price has responded as if it's game over. If you believe this business has a future then it's one to tuck away once you feel the price has dropped as far as it's going to go. Give it a month when the world is on holiday and everything drifts South, this might be down to 5p. The business isn't shrinking, indeed it's product seems to be going mainstream, it could be the default 'green' factor it just about every utility product a few years from now. Or of course something better could come along, but for now I don't know what that could be.
purchaseatthetop: Hi you want me back on EUA again? Funny old world. RNS on ITX leads to astonishing oversell. My portfolio takes a beating. Hey ho...that is investing. Get up. Dust yourself off. Get on with it. No tears. This morning, stonking RNS on AGL (equal weighting for me with ITX) and suddenly my portfolio is moving strongly the right direction. Swings and roundabouts. I still massively believe in ITX and will not sell any. This is part of the game. The 12.1p II really has me thinking. Why would they pay 12.1p knowing that this drop was likely with the 6 month figures? They art not idiots. I think we might have some good news soon. Anyway....your money, your call. GLA and what a week. Makes you glad to be alive!
chester9: Taken from Lutheran post on LSEuallmakeitup wrote: "Why would he play it down.? Does he want the share price to drop as the last two updates have been very lacklustre."John Shaw would arguably play it down because he is entitled to a performance bonus based on revenue growth, and this performance bonus is settled by awarding him newly issued shares in the company. The lower the share price, the more shares he receives. As a consequence, he is incentivised to grow the company's revenues as much as possible while keeping a lid on the share price until the bonus scheme ends at the end of 2022.The deferred consideration bonus scheme was put in place when Itaconix merged with Revolymer. The scheme was originally due to expire in 2020, but it was extended to the end of 2022 as part of the 2018 fund raise.Note 17 in the Annual Report (page 62) explains how the scheme works. In 2020, scheme members were entitled to a bonus of 50% of incremental sales above $3m. Sales for the year were $3.292m, so the bonus was (3,292m – 3m) * 0.5 = $146,000. The bonus was paid through the issuance of 1,923,389 new shares in the company as per the RNS of 9 April. John Shaw received 884,953 of the shares (46.0%) and Dr Yvon Durant received 205,802 (10.7%).2020's sales of $3.292m now becomes the base figure for the 2021 bonus.What's interesting about this deferred consideration is that it's a contingent liability for the company and it must therefore be reserved for in the accounts under fair value accounting. This in turn leads to the company having to project what its sales will be in 2021 and 2022 to compute the liability. Note 17 in the AR gives a gross value of $2.853m for this liability at 31 Dec 2020, of which $146,000 has now been settled. There is no breakdown of liability by year, so in theory we can only make guesses as to what is expected for revenue this year and next.However, there's a crucial bit of extra info in note 17: we're told that a 1% increase in the discount rate reduces the fair value liability by $46K. If you play around in a spreadsheet with different sales combinations and the cited discount rates for 2021 and 2022, you'll quickly see that high revenue growth for this year was never on the cards, but that management is forecasting revenues to surge in 2022. I make the numbers $3.9m for 2021 revenues and $9.9m for 2022, so revenue growth for next year is projected to be over 150%.
thordon: So I'm a researcher , so done a basic on chat on ITX on positive and negative chats. Jan 100% positive Feb 100% positive March 97% positive April 95% positive June 72% positive July 59% positive The point is looking back we had a group that was working together as a collective in research and data in ITX , since the the share price has risen and seen multiple accounts view negatives with no evidence. That would imply that we are being targeted for sells as we all know that very limited shares available as per last post on top 25% share holders.
paulboz: Patt: your short term predictions make you look extremely unreliable and give credibility to the likes of Liam & co. It's extremely unlikely that the share price of Itx will be 11p at EOD. It's a free country and all that but why keep making these short term guesses that pretty much much always turn out wrong?
ivor hunch: I think the market has probably agreed with my interpretation of yesterday's presentation. A good solid report but lacking the excitement to push the share price higher. Covid is obviously having a serious impact on sales and new products are being prepared but their impact will not be felt until 2022. Hopefully H2 will continue H1's growth, but don't expect fireworks. The recent rise in the share price was fuelled by short term speculators who will now look elsewhere for their excitement. None of the above means that ITX is not an excellent investment with huge long term potential, but for the moment the speculative froth has been blown away.
purchaseatthetop: It has been a masterclass in how to manage the process.... Need to raise cash Have to alert market to covid impact on first Half sales. Delays. Share price over exuberant Release trading update to dampen share price Release RNS of capital raise at almost exactly share price. Share price drops to exact same price as placing so no investor view of unfair dilution. Now blue skies ahead and worries over cash gone. Share price rises with all issues dealt with. Investors have the great feeling of having profits again. Absolutely brilliant. Well done JS and team.
1liam: and down comes the ITX share price. Surely as night follows day.once me your genius...answer the question that I always ask. If you cannot then who is the ignorant person?
purchaseatthetop: Talk about masterful message and financial management. Share price runs too high. RNS released that appears to be sub-optimum but with suggestions of new breakthroughs. Market only looks at short term revenue delays - drops to 11p JS releases NS that shows the major II is fully onboard at market share price. Cash sorted and advance notice of slower H1 2021 Everybody back onboard forgetting any reduced income and looking to the future. Masterclass. Respect.
Itaconix share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210730 23:28:01